Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia.
Saved in:
| Title: | Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia. |
|---|---|
| Authors: | Azevedo, Roberta S.1 (AUTHOR), Braish, Julie1 (AUTHOR), Gener-Ricos, Georgina1 (AUTHOR), Tang, Guilin2 (AUTHOR), Sasaki, Koji1 (AUTHOR), Montalban-Bravo, Guillermo1 (AUTHOR), Jabbour, Elias1 (AUTHOR), Ohanian, Maro1 (AUTHOR), Yilmaz, Musa1 (AUTHOR), Haddad, Fadi G.1 (AUTHOR), Chien, Kelly1 (AUTHOR), Ishizawa, Jo1 (AUTHOR), Short, Nicholas J.1 (AUTHOR), Maiti, Abhishek1 (AUTHOR), Swaminathan, Mahesh1 (AUTHOR), Kantarjian, Hagop1 (AUTHOR), Borthakur, Gautam1 (AUTHOR), Kadia, Tapan M.1 (AUTHOR) tkadia@mdanderson.org |
| Source: | Leukemia & Lymphoma. Jan2026, Vol. 67 Issue 1, p220-224. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 190717527 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Azevedo%2C+Roberta+S%2E%22">Azevedo, Roberta S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Braish%2C+Julie%22">Braish, Julie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gener-Ricos%2C+Georgina%22">Gener-Ricos, Georgina</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Guilin%22">Tang, Guilin</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sasaki%2C+Koji%22">Sasaki, Koji</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Montalban-Bravo%2C+Guillermo%22">Montalban-Bravo, Guillermo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jabbour%2C+Elias%22">Jabbour, Elias</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ohanian%2C+Maro%22">Ohanian, Maro</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yilmaz%2C+Musa%22">Yilmaz, Musa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Haddad%2C+Fadi+G%2E%22">Haddad, Fadi G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chien%2C+Kelly%22">Chien, Kelly</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ishizawa%2C+Jo%22">Ishizawa, Jo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Short%2C+Nicholas+J%2E%22">Short, Nicholas J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maiti%2C+Abhishek%22">Maiti, Abhishek</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Swaminathan%2C+Mahesh%22">Swaminathan, Mahesh</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kantarjian%2C+Hagop%22">Kantarjian, Hagop</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Borthakur%2C+Gautam%22">Borthakur, Gautam</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kadia%2C+Tapan+M%2E%22">Kadia, Tapan M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> tkadia@mdanderson.org</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jan2026, Vol. 67 Issue 1, p220-224. 5p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190717527 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2025.2568745 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 220 Titles: – TitleFull: Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Azevedo, Roberta S. – PersonEntity: Name: NameFull: Braish, Julie – PersonEntity: Name: NameFull: Gener-Ricos, Georgina – PersonEntity: Name: NameFull: Tang, Guilin – PersonEntity: Name: NameFull: Sasaki, Koji – PersonEntity: Name: NameFull: Montalban-Bravo, Guillermo – PersonEntity: Name: NameFull: Jabbour, Elias – PersonEntity: Name: NameFull: Ohanian, Maro – PersonEntity: Name: NameFull: Yilmaz, Musa – PersonEntity: Name: NameFull: Haddad, Fadi G. – PersonEntity: Name: NameFull: Chien, Kelly – PersonEntity: Name: NameFull: Ishizawa, Jo – PersonEntity: Name: NameFull: Short, Nicholas J. – PersonEntity: Name: NameFull: Maiti, Abhishek – PersonEntity: Name: NameFull: Swaminathan, Mahesh – PersonEntity: Name: NameFull: Kantarjian, Hagop – PersonEntity: Name: NameFull: Borthakur, Gautam – PersonEntity: Name: NameFull: Kadia, Tapan M. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 67 – Type: issue Value: 1 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |